Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Longeveron Inc. Director's Dealing 2022

Apr 15, 2022

35052_dirs_2022-04-15_be8f14dc-348c-4da0-a9f0-ea24f806ff0d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Longeveron Inc. (LGVN)
CIK: 0001721484
Period of Report: 2022-04-13

Reporting Person: DS MED LLC (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-04-13 Common Stock J 748694 Disposed 7024208 Direct

Footnotes

F1: Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

F2: Shares distributed to members of DS Med, LLC, for no consideration.